The purpose of this study is to evaluate the role of treatment of active Crohn's disease with a new drug (chimeric anti-TNF). The trial is a multi-center, placebo controlled tiral of 3 doses of anti-TNF and 1 dose of placebo in the treatment of active Crohn's Disease/100 patients who have active disease and who meet other entry criteria will be enrolled in approximately 15 center in the US and Europe.
Showing the most recent 10 out of 782 publications